Question 1

Which Wall Street gurus hold Protagonist Therapeutics Inc (PTGX)?

Accepted Answer

Per the latest SEC 13F filings, 3 Wall Street gurus hold PTGX. Top holders include 블랙록, 켄 피셔, JP모건 체이스, with a combined position value of about $1.07B.

Question 2

What sector does Protagonist Therapeutics Inc belong to?

Accepted Answer

Protagonist Therapeutics Inc (PTGX) is in the Biotechnology sector / Biotechnology industry, listed on NASDAQ NMS - GLOBAL MARKET.

Question 3

What are the key financial metrics for Protagonist Therapeutics Inc?

Accepted Answer

Key metrics for Protagonist Therapeutics Inc (PTGX): EPS $-1.80, Beta 1.85. Live price and chart are at the top of the page.

Question 4

What is a 13F report?

Accepted Answer

A 13F is a quarterly filing institutional investors submit to the US Securities and Exchange Commission (SEC) disclosing their equity holdings. It is mandatory for managers with at least $100M in AUM and must be filed within 45 days of the quarter end.

#	Investor	Weight	Shares	Value	Activity
1	BlackRock BlackRock Inc	0.02%	9,779,369	$1.03B	HOLD
2	Ken Fisher Fisher Asset Management LLC	0.01%	173,971	$18.34M	HOLD
3	JPMorgan Chase JPMorgan Asset Management	0.00%	172,990	$17.28M	HOLD

Insider	Title	Type	Shares	Value	Date
PATEL DINESH V PH D	President and CEO	SELL	1,460	--	4/23/2026
Ali Asif	Chief Financial Officer	SELL	1,750	$0.2M	4/20/2026

Protagonist Therapeutics Inc

Holders (3)

Insider Trades (2)